Literature DB >> 3286232

Immunoreactive gastric inhibitory polypeptide.

T Krarup1.   

Abstract

Mesh：

Substances：

Year:  1988        PMID： 3286232     DOI： 10.1210/edrv-9-1-122

Source DB:  PubMed          Journal:  Endocr Rev        ISSN： 0163-769X            Impact factor:   19.871


× No keyword cloud information.
  18 in total

Review 1.  Targeting beta-cell mass in type 2 diabetes: promise and limitations of new drugs based on incretins.

Authors:  Marzieh Salehi; Benedikt A Aulinger; David A D'Alessio
Journal:  Endocr Rev       Date:  2008-02-21       Impact factor: 19.871

Review 2.  Glucagon-like peptide-1: from extract to agent. The Claude Bernard Lecture, 2005.

Authors:  J J Holst
Journal:  Diabetologia       Date:  2006-01-14       Impact factor: 10.122

Review 3.  Incretins and the development of type 2 diabetes.

Authors:  Juris J Meier; Michael A Nauck
Journal:  Curr Diab Rep       Date:  2006-06       Impact factor: 4.810

4.  GIP(3-30)NH2 is an efficacious GIP receptor antagonist in humans: a randomised, double-blinded, placebo-controlled, crossover study.

Authors:  Lærke S Gasbjerg; Mikkel B Christensen; Bolette Hartmann; Amalie R Lanng; Alexander H Sparre-Ulrich; Maria B N Gabe; Flemming Dela; Tina Vilsbøll; Jens J Holst; Mette M Rosenkilde; Filip K Knop
Journal:  Diabetologia       Date:  2017-09-25       Impact factor: 10.122

5.  Postnatal development of intestinal endocrine cell populations in the water buffalo.

Authors:  C Lucini; P De Girolamo; L Coppola; G Paino; L Castaldo
Journal:  J Anat       Date:  1999-10       Impact factor: 2.610

6.  The glucose dependent insulinotropic polypeptide response to oral glucose and mixed meals is increased in patients with type 2 (non-insulin-dependent) diabetes mellitus.

Authors:  I R Jones; D R Owens; S Luzio; S Williams; T M Hayes
Journal:  Diabetologia       Date:  1989-09       Impact factor: 10.122

7.  Influence of gastric inhibitory polypeptide on pentagastrin-stimulated gastric acid secretion in patients with type 2 diabetes and healthy controls.

Authors:  Juris J Meier; Michael A Nauck; Bartholomaeus Kask; Jens J Holst; Carolyn F Deacon; Wolfgang E Schmidt; Baptist Gallwitz
Journal:  World J Gastroenterol       Date:  2006-03-28       Impact factor: 5.742

Review 8.  Is the diminished incretin effect in type 2 diabetes just an epi-phenomenon of impaired beta-cell function?

Authors:  Juris J Meier; Michael A Nauck
Journal:  Diabetes       Date:  2010-05       Impact factor: 9.461

Review 9.  Incretins, insulin secretion and Type 2 diabetes mellitus.

Authors:  T Vilsbøll; J J Holst
Journal:  Diabetologia       Date:  2004-02-13       Impact factor: 10.122

10.  Comparison of Bariatric Surgical Procedures for Diabetes Remission: Efficacy and Mechanisms.

Authors:  Marion L Vetter; Scott Ritter; Thomas A Wadden; David B Sarwer
Journal:  Diabetes Spectr       Date:  2012-11-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.